MyAverix Finance
HK · Healthcare
China Resources Pharmaceutical Group Ltd (3320)
Drug Manufacturers - Specialty & Generic
China Resources Pharmaceutical Group Ltd (3320) is listed on HK in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-21, reported market cap is $29.84B, P/E ratio is 6.42, net margin is 1.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 3320
China Resources Pharmaceutical Group Ltd (3320) — FAQ
What is China Resources Pharmaceutical Group Ltd's market cap?
China Resources Pharmaceutical Group Ltd (3320) has a reported market cap of $29.84B (data as of 2026-05-21).
What is 3320's P/E ratio?
The price-to-earnings (P/E) ratio for China Resources Pharmaceutical Group Ltd (3320) is 6.42 (data as of 2026-05-21).
Does China Resources Pharmaceutical Group Ltd pay a dividend?
Dividend yield is not available in the current snapshot for China Resources Pharmaceutical Group Ltd (3320). Check the MyAverix Finance app for the latest dividend data.
What sector is China Resources Pharmaceutical Group Ltd in?
China Resources Pharmaceutical Group Ltd (3320) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 3320 listed on?
3320 is listed on HK.
What is China Resources Pharmaceutical Group Ltd's net margin?
China Resources Pharmaceutical Group Ltd (3320) reports a net margin of 1.5% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.